264 related articles for article (PubMed ID: 22523352)
1. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD.
Soler N; Esperatti M; Ewig S; Huerta A; Agustí C; Torres A
Eur Respir J; 2012 Dec; 40(6):1344-53. PubMed ID: 22523352
[TBL] [Abstract][Full Text] [Related]
2. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A
Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
[TBL] [Abstract][Full Text] [Related]
3. [Not all exacerbations of chronic obstructive pulmonary disease should be treated with antibiotics].
Nielsen SK; Lange P
Ugeskr Laeger; 2017 Apr; 179(15):. PubMed ID: 29332624
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
[TBL] [Abstract][Full Text] [Related]
6. Relation of sputum colour to bacterial load in acute exacerbations of COPD.
Brusse-Keizer MG; Grotenhuis AJ; Kerstjens HA; Telgen MC; van der Palen J; Hendrix MG; van der Valk PD
Respir Med; 2009 Apr; 103(4):601-6. PubMed ID: 19027281
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC
Cochrane Database Syst Rev; 2006 Apr; (2):CD004403. PubMed ID: 16625602
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary disease.
Brightling CE
Ann Am Thorac Soc; 2013 Dec; 10 Suppl():S214-9. PubMed ID: 24313775
[TBL] [Abstract][Full Text] [Related]
11. WITHDRAWN: Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC
Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD004403. PubMed ID: 21249661
[TBL] [Abstract][Full Text] [Related]
12. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review and Meta-Analysis of Sputum Purulence to Predict Bacterial Infection in COPD Exacerbations.
Chen K; Pleasants KA; Pleasants RA; Beiko T; Washburn RG; Yu Z; Zhai S; Drummond MB
COPD; 2020 Jun; 17(3):311-317. PubMed ID: 32456479
[TBL] [Abstract][Full Text] [Related]
14. Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD.
Soler N; Torres A
Eur Respir J; 2013 Jan; 41(1):248-9. PubMed ID: 23277527
[No Abstract] [Full Text] [Related]
15. Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD.
Aggarwal D; Mohapatra PR; Aggarwal P
Eur Respir J; 2013 Jan; 41(1):248. PubMed ID: 23277526
[No Abstract] [Full Text] [Related]
16. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
Peng C; Tian C; Zhang Y; Yang X; Feng Y; Fan H
Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
[TBL] [Abstract][Full Text] [Related]
18. Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice.
Llor C; Bjerrum L; Munck A; Hansen MP; Córdoba GC; Strandberg EL; Ovhed I; Radzeviciene R; Cots JM; Reutskiy A; Caballero L
Ther Adv Respir Dis; 2013 Jun; 7(3):131-7. PubMed ID: 23325784
[TBL] [Abstract][Full Text] [Related]
19. [The changes and clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease].
Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jul; 29(7):444-7. PubMed ID: 17045042
[TBL] [Abstract][Full Text] [Related]
20. Systemic inflammation and the effects of short-term antibiotic treatment for PPM positive patients with stable COPD.
Wang JX; Li HQ; Zhang F; Ning W
Int J Chron Obstruct Pulmon Dis; 2019; 14():1923-1932. PubMed ID: 31692553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
